Black Diamond Therapeutics, Inc. (BDTX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Black Diamond Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 6.18x | -1.69x | -1.50x | -0.72x | -1.54x | -15.68x |
| P/B Ratio | 1.23x | 1.41x | 1.06x | 0.56x | 0.98x | 3.43x |
| P/S Ratio | 1.97x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 99.5% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 28.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 32.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 28.8% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 8.42x | 4.92x | 6.82x | 8.37x | 9.12x | 22.48x |
| Quick Ratio | 8.42x | 4.92x | 6.82x | 8.37x | 9.12x | 22.48x |
| Leverage | ||||||
| Debt/Equity | 0.13x | 0.27x | 0.22x | 0.24x | 0.15x | 0.03x |
YoY = year-over-year change. Source: FMP..